Invagen Pharmaceuticals

Rediff.com » News » Invagen Pharmaceuticals

News for Invagen Pharmaceuticals

Business

Cipla to acquire two US-based pharma cos for $550 million

Cipla Ltd, India's fourth-largest drugmaker by sales, said on Friday it has agreed to buy two generics businesses in the United States in an all-cash deal worth $550 million to get access to a wide......

Earning woes drag markets lower; TCS, HUL lead fall

Markets closed lower for the third straight day with IT giant TCS leading the fall after its Q2 results missed street expectations while lower dollar revenue guidance from Infosys on Monday also......

Cipla's brilliant plan to make it big in the US

Cipla, though late in changing its strategy for international markets, has in recent years taken an inorganic route for expansion. Cipla’s acquisition of the businesses of InvaGen......

'Cipla has emerged as a great "catchment area" for talent'

An insider said that over the past decade or so Cipla has become immune to the exits of leaders. There have been no directional change in the long-term strategies. This is a pandemic-hit year, but......

Pharma cos in deals to expand product basket

With marketing licence deals being struck virtually every week in the Indian pharmaceutical sector in the last few months and more in the offing, Indian companies are gearing up to strengthen their......

Rediff News

Invagen Pharmaceuticals

News for Invagen Pharmaceuticals

Cipla to acquire two US-based pharma cos for $550 million

Earning woes drag markets lower; TCS, HUL lead fall

Cipla's brilliant plan to make it big in the US

'Cipla has emerged as a great "catchment area" for talent'

Pharma cos in deals to expand product basket

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS